Answers are grounded in this paper and cite their sources.
Atopic dermatitis (AD) is a chronic inflammatory skin disorder, which is characterized by persistent itching and eczematous lesions, and affects all age groups (Boguniewicz et al., 2018, Sayaseng and Vernon, 2018). Novel effective topical therapies with improved tolerability and fewer adverse events (AEs) are needed to improve the management of mild-to-moderate AD.
No takes yet. Share an insight, caveat, or question.
Mikol et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: